SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cellegy Pharmaceuticals (CLGY) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (247)4/25/2002 7:32:22 PM
From: Sergio H  Read Replies (1) | Respond to of 322
 
Thanks for the Gruntal info. I'll accept your reading that there's nothing more than estimates.

The 2003 estimate gives CLGY a forward PE of about 5. Assigning a more appropriate PE gives the stock a price in the 30s. Even a conservative PE of 20 = a stock price in the 20s.

Gruntal's coverage could lead to something more. I believe that they're a sell-side analyst. I'll try to find out if anything like a secondary offering is planned.

Thanks again TD.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News